Molecular biology underlying the clinical heterogeneity of prostate cancer: an update.

Abstract excerpt

CONTEXT: Recent studies have uncovered a number of possible mechanisms by which prostate cancers can become resistant to systemic androgen deprivation, most involving androgen-independent reactivation of the androgen receptor. Genome-wide expression analysis with microarrays has identified a wide array of genes that are differentially expressed in metastatic prostate cancers compared to primary nonrecurrent...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Prostate Cancer Diagnosis and Treatment
• Share to Prostate Cancer Treatment and Research
• Share to Radiopharmaceutical Chemistry and Applications